Latest Breaking News On - Revance therapeutics - Page 4 : comparemela.com
A California federal judge has dismissed a lawsuit from the investors of Revance Therapeutics Inc. accusing it and several executives of concealing quality control concerns that eventually led the U.S. Food and Drug Administration to deny the company a license for its wrinkle injectable, saying the defendants may not have known the approval timeline they presented was unattainable.
Drug-administration
Revance-therapeutics-inc
Sydney-price
Revance-therapeutics